Common use of Selling Securityholder Notice and Questionnaire Clause in Contracts

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Inc., a Delaware corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__], 2020 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Inc., a Delaware corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]April 14, 2020 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share 0.001 (the “Common Stock”), of Amesite Inc.WorldWater & Power Corp., a Delaware corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]July 25, 2020 2005 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers Holder named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Ascent Solar Technologies, Inc., a Delaware corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-3 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]June 17, 2020 2013 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share stock (the “Common StockRegistrable Securities”), ) of Amesite Inc.Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__], 2020 Agreement (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein) of which this document is an exhibit. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share .0001 (the “Common Stock”), of Amesite Inc.Titan Iron Ore Corp., a Delaware Nevada corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [February __], 2020 2013 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share .0001 (the “Common Stock”), of Amesite Inc.Titan Iron Ore Corp., a Delaware Nevada corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]October 17, 2020 2012 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Pro Elite, Inc., a Delaware New Jersey corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]October 3, 2020 2006 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, no par value $0.0001 per share (the “Common Stock”), of Amesite Inc.CyberDefender Corporation, a Delaware California corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]______________, 2020 2008 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers Purchaser named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Inc.Plastinum Polymer Technologies Corp., a Delaware corporation (the corporation(the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]November 6, 2020 2007 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share stock (the “Common Stock”), of Amesite Nightfood Holdings, Inc., a Delaware Nevada corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]December 10, 2020 2021 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 .0001 per share (the “Common Stock”), of Amesite Inc.Crdentia Corp., a Delaware corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-3 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]December [ , 2020 2005 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Pro Elite, Inc., a Delaware New Jersey corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Investor Rights Agreement, dated as of [__]June 15, 2020 2007 (the “Amended and Restated Registration Investor Rights Agreement”), among the Company and the Purchasers holder named therein. A copy of the Amended and Restated Registration Investor Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Investor Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Inc.Matinee Media Corporation, a Delaware corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]April 3, 2020 2006 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, no par value $0.0001 per share (the “Common Stock”), of Amesite Inc.NutraCea, a Delaware California corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]____________, 2020 2006 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 0.001 per share (the “Common Stock”), of Amesite Inc.eMagin Corporation, a Delaware corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]December 18, 2020 2008 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share stock (the “Common Stock”), of Amesite Inc.White River Energy Corp, a Delaware Nevada corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]August 10, 2020 2023 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers Purchaser named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share stock (the “Common Stock”), of Amesite Encision Inc., a Delaware Colorado corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]December 17, 2020 2013 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, no par value $0.0001 per share (the “Common Stock”), of Amesite Inc.CyberDefender Corporation, a Delaware California corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [March __]_, 2020 2007 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Oncolix, Inc., a Delaware Florida corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Rights Agreement, dated as of [__]May , 2020 2018 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers Purchaser named therein. A copy of the Amended and Restated Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.

Selling Securityholder Notice and Questionnaire. The undersigned beneficial owner of common stock, par value $0.0001 per share (the “Common Stock”), of Amesite Pro Elite, Inc., a Delaware New Jersey corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement on Form SB-2 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Amended and Restated Registration Investor Rights Agreement, dated as of [December __]_, 2020 2006 (the “Amended and Restated Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Amended and Restated Registration Investor Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Amended and Restated Registration Rights Agreement. Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related prospectus.